Ebselen inhibits iron-induced tau phosphorylation by attenuating DMT1 up-regulation and cellular iron uptake

Neurochemistry International

Volumn 61, Issue 3, 2012, Pages 334-340

  Xie, Ling ^a,b   Zheng, Wei ^a   Xin, Na ^a   Xie, Jing Wei ^a   Wang, Tao ^a   Wang, Zhan You ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b JINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Cyclin dependent kinase 5; Divalent metal transporter 1; Ebselen; Glycogen synthase kinase; Tau

Indexed keywords

CYCLIN DEPENDENT KINASE 5; EBSELEN; FERROUS SULFATE; GLYCOGEN SYNTHASE KINASE 3BETA; IRON; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; REACTIVE OXYGEN METABOLITE; TAU PROTEIN;

ARTICLE; ATTENUATION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INHIBITION KINETICS; INTRACELLULAR SIGNALING; IRON TRANSPORT; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION;

AZOLES; BLOTTING, WESTERN; CELL LINE, TUMOR; FLOW CYTOMETRY; HUMANS; IRON; ORGANOSELENIUM COMPOUNDS; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; TAU PROTEINS; TRANSCRIPTION FACTORS; UP-REGULATION;

MUS MUSCULUS;

EID: 84864188531     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2012.05.016     Document Type: Article

References (54)

1. A. Alvarez, J.P. Munoz, and R.B. Maccioni A Cdk5-p35 stable complex is involved in the beta-amyloid-induced deregulation of Cdk5 activity in hippocampal neurons Exp. Cell Res. 264 2001 266 274 (Pubitemid 32980231)
2. P.D. Buckett, and M. Wessling-Resnick Small molecule inhibitors of divalent metal transporter-1 Am. J. Physiol. Gastrointest. Liver Physiol. 296 2009 G798 G804
3. F.B. Centuriao, C.L. Corte, M.W. Paixao, A.L. Braga, G. Zeni, T. Emanuelli, and J.B. Rocha Effect of ebselen and organochalcogenides on excitotoxicity induced by glutamate in isolated chick retina Brain Res. 1039 2005 146 152 (Pubitemid 40386837)
4. J.R. Connor, and S.Y. Lee HFE mutations and Alzheimer's disease J. Alzheimers Dis. 10 2006 267 276 (Pubitemid 44763997)
5. D.M. de Silva, and S.D. Aust Ferritin and ceruloplasmin in oxidative damage: review and recent findings Can. J. Physiol. Pharmacol. 71 1993 715 720 (Pubitemid 24025089)
6. F. Denizot, and R. Lang Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability J. Immunol. Methods 89 1986 271 277 (Pubitemid 16080782)
7. J.T. Egana, C. Zambrano, M.T. Nunez, C. Gonzalez-Billault, and R.B. Maccioni Iron-induced oxidative stress modify tau phosphorylation patterns in hippocampal cell cultures Biometals 16 2003 215 223 (Pubitemid 36140231)
8. K.M. Erikson, and M. Aschner Increased manganese uptake by primary astrocyte cultures with altered iron status is mediated primarily by divalent metal transporter Neurotoxicology 27 2006 125 130 (Pubitemid 41745015)
9. M.D. Fleming, M.A. Romano, M.A. Su, L.M. Garrick, M.D. Garrick, and N.C. Andrews Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport Proc. Natl. Acad. Sci. USA 95 1998 1148 1153 (Pubitemid 28124927)
10. M.D. Fleming, C.C. Trenor 3rd, M.A. Su, D. Foernzler, D.R. Beier, W.F. Dietrich, and N.C. Andrews Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene Nat. Genet. 16 1997 383 386 (Pubitemid 27323306)
11. H. Gunshin, B. Mackenzie, U.V. Berger, Y. Gunshin, M.F. Romero, W.F. Boron, S. Nussberger, J.L. Gollan, and M.A. Hediger Cloning and characterization of a mammalian proton-coupled metal-ion transporter Nature 388 1997 482 488 (Pubitemid 27328927)
12. B. Halliwell Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment Drugs Aging 18 2001 685 716 (Pubitemid 32948277)
13. C. Hooper, R. Killick, and S. Lovestone The GSK3 hypothesis of Alzheimer's disease J. Neurochem. 104 2008 1433 1439 (Pubitemid 351316776)
14. E. House, J. Collingwood, A. Khan, O. Korchazkina, G. Berthon, and C. Exley Aluminium, iron, zinc and copper influence the in vitro formation of amyloid fibrils of Abeta42 in a manner which may have consequences for metal chelation therapy in Alzheimer's disease J. Alzheimers Dis. 6 2004 291 301 (Pubitemid 38823264)
15. J.P. Hu, J.W. Xie, C.Y. Wang, T. Wang, X. Wang, S.L. Wang, W.P. Teng, and Z.Y. Wang Valproate reduces tau phosphorylation via cyclin-dependent kinase 5 and glycogen synthase kinase 3 signaling pathways Brain Res. Bull. 85 2011 194 200
16. K. Imahori, and T. Uchida Physiology and pathology of tau protein kinases in relation to Alzheimer's disease J Biochem 121 1997 179 188 (Pubitemid 27096190)
17. D.J. Lane, S.R. Robinson, H. Czerwinska, G.M. Bishop, and A. Lawen Two routes of iron accumulation in astrocytes: ascorbate-dependent ferrous iron uptake via the divalent metal transporter (DMT1) plus an independent route for ferric iron Biochem. J. 432 2010 123 132
18. S. Leclerc, M. Garnier, R. Hoessel, D. Marko, J.A. Bibb, G.L. Snyder, P. Greengard, J. Biernat, Y.Z. Wu, E.M. Mandelkow, G. Eisenbrand, and L. Meijer Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors? J. Biol. Chem. 276 2001 251 260 (Pubitemid 32050314)
19. S.Y. Lee, S.M. Patton, R.J. Henderson, and J.R. Connor Consequences of expressing mutants of the hemochromatosis gene (HFE) into a human neuronal cell line lacking endogenous HFE FASEB J. 21 2007 564 576 (Pubitemid 46213503)
20. H. Li, F. Li, H. Sun, and Z.M. Qian Membrane-inserted conformation of transmembrane domain 4 of divalent-metal transporter Biochem. J. 372 2003 757 766 (Pubitemid 36760389)
21. M.A. Lovell, S. Xiong, C. Xie, P. Davies, and W.R. Markesbery Induction of hyperphosphorylated tau in primary rat cortical neuron cultures mediated by oxidative stress and glycogen synthase kinase-3 J. Alzheimers Dis. 6 2004 659 671 discussion 673-681 (Pubitemid 40164172)
22. E.M. Mandelkow, and E. Mandelkow Tau in Alzheimer's disease Trends Cell Biol. 8 1998 425 427 (Pubitemid 28529713)
23. E. Martinez-Vila, and P.I. Sieira Current status and perspectives of neuroprotection in ischemic stroke treatment Cerebrovasc. Dis. 11 Suppl 1 2001 60 70
24. S. Minegishi, A. Asada, S. Miyauchi, T. Fuchigami, T. Saito, and S. Hisanaga Membrane association facilitates degradation and cleavage of the cyclin-dependent kinase 5 activators p35 and p39 Biochemistry 49 2010 5482 5493
25. A. Monji, H. Utsumi, T. Ueda, T. Imoto, I. Yoshida, S. Hashioka, K. Tashiro, and N. Tashiro Amyloid-beta-protein (A beta) (25-35)-associated free radical generation is strongly influenced by the aggregational state of the peptides Life Sci. 70 2002 833 841 (Pubitemid 34075571)
26. Y. Nevo, and N. Nelson The mutation F227I increases the coupling of metal ion transport in DCT1 J. Biol. Chem. 279 2004 53056 53061 (Pubitemid 40051805)
27. I. Pelizzoni, R. Macco, M.F. Morini, D. Zacchetti, F. Grohovaz, and F. Codazzi Iron handling in hippocampal neurons: activity-dependent iron entry and mitochondria-mediated neurotoxicity Aging Cell 10 2011 172 183
28. V. Picard, G. Govoni, N. Jabado, and P. Gros Nramp 2 (DCT1/DMT1) expressed at the plasma membrane transports iron and other divalent cations into a calcein-accessible cytoplasmic pool J. Biol. Chem. 275 2000 35738 35745
29. K.E. Plant, E. Anderson, N. Simecek, R. Brown, S. Forster, J. Spinks, N. Toms, G.G. Gibson, J. Lyon, and N. Plant The neuroprotective action of the mood stabilizing drugs lithium chloride and sodium valproate is mediated through the up-regulation of the homeodomain protein Six1 Toxicol. Appl. Pharmacol. 235 2009 124 134
30. L.O. Porciuncula, J.B. Rocha, C.R. Boeck, D. Vendite, and D.O. Souza Ebselen prevents excitotoxicity provoked by glutamate in rat cerebellar granule neurons Neurosci. Lett. 299 2001 217 220 (Pubitemid 32124850)
31. D.W. Reif Ferritin as a source of iron for oxidative damage Free Radic. Biol. Med. 12 1992 417 427
32. S. Rivera-Mancia, I. Perez-Neri, C. Rios, L. Tristan-Lopez, L. Rivera-Espinosa, and S. Montes The transition metals copper and iron in neurodegenerative diseases Chem. Biol. Interact. 186 2010 184 199
33. P. Rudrabhatla, Y.L. Zheng, N.D. Amin, S. Kesavapany, W. Albers, and H.C. Pant Pin1-dependent prolyl isomerization modulates the stress-induced phosphorylation of high molecular weight neurofilament protein J. Biol. Chem. 283 2008 26737 26747
34. I. Saito, T. Asano, K. Sano, K. Takakura, H. Abe, T. Yoshimoto, H. Kikuchi, T. Ohta, and S. Ishibashi Neuroprotective effect of an antioxidant, ebselen, in patients with delayed neurological deficits after aneurysmal subarachnoid hemorrhage Neurosurgery 42 1998 269 277 discussion 277-268
35. J. Salazar, N. Mena, S. Hunot, A. Prigent, D. Alvarez-Fischer, M. Arredondo, C. Duyckaerts, V. Sazdovitch, L. Zhao, L.M. Garrick, M.T. Nunez, M.D. Garrick, R. Raisman-Vozari, and E.C. Hirsch Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease Proc. Natl. Acad. Sci. USA 105 2008 18578 18583
36. T. Satoh, K. Ishige, and Y. Sagara Protective effects on neuronal cells of mouse afforded by ebselen against oxidative stress at multiple steps Neurosci. Lett. 371 2004 1 5 (Pubitemid 39410504)
37. L.M. Sayre, M.A. Smith, and G. Perry Chemistry and biochemistry of oxidative stress in neurodegenerative disease Curr. Med. Chem. 8 2001 721 738 (Pubitemid 32427903)
38. L. Sereno, M. Coma, M. Rodriguez, P. Sanchez-Ferrer, M.B. Sanchez, I. Gich, J.M. Agullo, M. Perez, J. Avila, C. Guardia-Laguarta, J. Clarimon, A. Lleo, and T. Gomez-Isla A novel GSK-3beta inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo Neurobiol. Dis. 35 2009 359 367
39. R.W. Shin, T.P. Kruck, H. Murayama, and T. Kitamoto A novel trivalent cation chelator Feralex dissociates binding of aluminum and iron associated with hyperphosphorylated tau of Alzheimer's disease Brain Res. 961 2003 139 146 (Pubitemid 36090130)
40. M.A. Smith, P.L. Harris, L.M. Sayre, and G. Perry Iron accumulation in Alzheimer disease is a source of redox-generated free radicals Proc. Natl. Acad. Sci. USA 94 1997 9866 9868 (Pubitemid 27408156)
41. M.A. Smith, X. Zhu, M. Tabaton, G. Liu, D.W. McKeel Jr., M.L. Cohen, X. Wang, S.L. Siedlak, B.E. Dwyer, T. Hayashi, M. Nakamura, A. Nunomura, and G. Perry Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment J. Alzheimers Dis. 19 2010 363 372
42. S. Soe-Lin, S.S. Apte, M.R. Mikhael, L.K. Kayembe, G. Nie, and P. Ponka Both Nramp1 and DMT1 are necessary for efficient macrophage iron recycling Exp. Hematol. 38 2010 609 617
43. P. Strocchi, A. Pession, and B. Dozza Up-regulation of cDK5/p35 by oxidative stress in human neuroblastoma IMR-32 cells J. Cell Biochem. 88 2003 758 765 (Pubitemid 36258825)
44. S. Tandy, M. Williams, A. Leggett, M. Lopez-Jimenez, M. Dedes, B. Ramesh, S.K. Srai, and P. Sharp Nramp2 expression is associated with pH-dependent iron uptake across the apical membrane of human intestinal Caco-2 cells J. Biol. Chem. 275 2000 1023 1029 (Pubitemid 30051149)
45. X.S. Wang, S. Lee, Z. Simmons, P. Boyer, K. Scott, W. Liu, and J. Connor Increased incidence of the Hfe mutation in amyotrophic lateral sclerosis and related cellular consequences J. Neurol. Sci. 227 2004 27 33 (Pubitemid 39491122)
46. H.A. Wetli, P.D. Buckett, and M. Wessling-Resnick Small-molecule screening identifies the selanazal drug ebselen as a potent inhibitor of DMT1-mediated iron uptake Chem. Biol. 13 2006 965 972 (Pubitemid 44375173)
47. H. Xu, H. Jiang, J. Wang, and J. Xie Rg1 protects the MPP+-treated MES23.5 cells via attenuating DMT1 up-regulation and cellular iron uptake Neuropharmacology 58 2010 488 494
48. K. Yamagata, S. Ichinose, A. Miyashita, and M. Tagami Protective effects of ebselen, a seleno-organic antioxidant on neurodegeneration induced by hypoxia and reperfusion in stroke-prone spontaneously hypertensive rat Neuroscience 153 2008 428 435
49. T. Yamaguchi, K. Sano, K. Takakura, I. Saito, Y. Shinohara, T. Asano, and H. Yasuhara Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial Ebselen study group. Stroke 29 1998 12 17 (Pubitemid 28046934)
50. S.D. Yan, S.F. Yan, X. Chen, J. Fu, M. Chen, P. Kuppusamy, M.A. Smith, G. Perry, G.C. Godman, and P. Nawroth Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid beta-peptide Nat. Med. 1 1995 693 699
51. S. Yu, W. Zheng, N. Xin, Z.H. Chi, N.Q. Wang, Y.X. Nie, W.Y. Feng, and Z.Y. Wang Curcumin prevents dopaminergic neuronal death through inhibition of the c-Jun N-terminal kinase pathway Rejuvenation Res. 13 2010 55 64
52. L. Zecca, M.B. Youdim, P. Riederer, J.R. Connor, and R.R. Crichton Iron, brain ageing and neurodegenerative disorders Nat. Rev. Neurosci. 5 2004 863 873 (Pubitemid 39482155)
53. S. Zhang, J. Wang, N. Song, J. Xie, and H. Jiang Up-regulation of divalent metal transporter 1 is involved in 1-methyl-4-phenylpyridinium (MPP(+))-induced apoptosis in MES23.5 cells Neurobiol. Aging 30 2009 1466 1476
54. W. Zheng, N. Xin, Z.H. Chi, B.L. Zhao, J. Zhang, J.Y. Li, and Z.Y. Wang Divalent metal transporter 1 is involved in amyloid precursor protein processing and Abeta generation Faseb J. 23 2009 4207 4217